chronic heart diseases
TRANSCRIPT
8/11/2019 Chronic Heart Diseases
http://slidepdf.com/reader/full/chronic-heart-diseases 1/54
CHRONIC HEART DISEASES
8/11/2019 Chronic Heart Diseases
http://slidepdf.com/reader/full/chronic-heart-diseases 2/54
Review of ANATOMY & PHYSIOLOGY
8/11/2019 Chronic Heart Diseases
http://slidepdf.com/reader/full/chronic-heart-diseases 5/54
What is Cardiac Output?
What is Stroke Volume?
What is normal HR?
Why are these important?
ethelRN
8/11/2019 Chronic Heart Diseases
http://slidepdf.com/reader/full/chronic-heart-diseases 7/54
Factors affecting Stroke Volume
Preload: the amount of blood remaining inthe ventricles at the end of diastole or thepressure generated at the end of diastole
Contractility: is the ability of the cardiacmuscle fibers to shorten and produce amuscle contraction.
Afterload: amount of pressure the Ventriclemust overcome to eject blood volume out
8/11/2019 Chronic Heart Diseases
http://slidepdf.com/reader/full/chronic-heart-diseases 9/54
Autonomic Nervous SystemBuilt in control center of the body
Regulates functions not under conscious control
Blood vessels innervated by sympathetic system
* Fight or flight
Nerve endings are adrenergic and neurotransmitteris norepinephrine
- Increases HR and BP
Parasympathetic is responsible for rest and digest
Cholinergics are the nerve endings and acetylcholine isthe neurotransmitter
- Decreases HR and BP
Parasympathetic and sympathetic innervates heart
ethelRN
8/11/2019 Chronic Heart Diseases
http://slidepdf.com/reader/full/chronic-heart-diseases 10/54
Examine !!!
General appearance
Mentation
Color
Neck Veins
Palpations
Turgor
Cap Refill
Pulses
Auscultation
8/11/2019 Chronic Heart Diseases
http://slidepdf.com/reader/full/chronic-heart-diseases 11/54
• Atherosclerosis is the abnormal accumulation oflipid deposits and fibrous tissue within arterialwalls and lumen.
•In coronary atherosclerosis, blockages andnarrowing of the coronary vessels reduce bloodflow to the myocardium.
• Cardiovascular disease is the leading cause of
death in the United States for men and women ofall racial and ethnic groups.
• CAD, coronary artery disease, is the most
prevalent cardiovascular disease in adults.
8/11/2019 Chronic Heart Diseases
http://slidepdf.com/reader/full/chronic-heart-diseases 12/54
• Symptoms are due to myocardial ischemia
• Symptoms and complications are related to the
location and degree of vessel obstruction
• Angina pectoris
• Myocardial infarction
•
Heart failure• Sudden cardiac death
8/11/2019 Chronic Heart Diseases
http://slidepdf.com/reader/full/chronic-heart-diseases 13/54
• Which is considered a modifiable risk
factor for coronary artery disease?
a. Race
b. Gender
c. Family history
d. Cigarette smoking
8/11/2019 Chronic Heart Diseases
http://slidepdf.com/reader/full/chronic-heart-diseases 14/54
• D
•
A modifiable risk factor for coronary arterydisease is cigarette smoking. Race,
gender, and family history are
nonmodifiable risk factors.
8/11/2019 Chronic Heart Diseases
http://slidepdf.com/reader/full/chronic-heart-diseases 15/54
• The most common symptom of myocardial
ischemia is chest pain; however, some
individuals may be asymptomatic or have
atypical symptoms such as weakness, dyspnea,
and nausea.
• Atypical symptoms are more common in
women and in persons who are older, or who
have a history of heart failure or diabetes.
8/11/2019 Chronic Heart Diseases
http://slidepdf.com/reader/full/chronic-heart-diseases 16/54
• A syndrome characterized by episodes or
paroxysmal pain or pressure in the anterior
chest caused by insufficient coronary blood
flow.
8/11/2019 Chronic Heart Diseases
http://slidepdf.com/reader/full/chronic-heart-diseases 17/54
• Physical exertion or emotional stress increases
myocardial oxygen demand and the coronary
vessels are unable to supply sufficient bloodflow to meet the oxygen demand.
• Exposure to cold, which can cause
vasoconstriction and elevated blood pressure,
with increased oxygen demand
8/11/2019 Chronic Heart Diseases
http://slidepdf.com/reader/full/chronic-heart-diseases 18/54
• Eating a heavy meal, which increases the blood flow to the mesenteric area for digestion,
thereby reducing the blood supply available to
the heart muscle; in a severely compromisedheart, shunting of blood for digestion can be
sufficient to induce anginal pain
•Stress or any emotion-provoking situation,causing the release of catecholamines, which
increases blood pressure, heart rate, and
myocardial workload.
8/11/2019 Chronic Heart Diseases
http://slidepdf.com/reader/full/chronic-heart-diseases 20/54
• May be described as tightness, choking, or aheavy sensation.
• Frequently retrosternal and may radiate to neck, jaw, shoulders, back or arms (usually left).
• Anxiety frequently accompanies the pain.
• Other symptoms may occur: dyspnea/shortness of breath, dizziness, nausea, and vomiting.
•
The pain of typical angina subsides with rest or NTG.
• Unstable angina is characterized by increasedfrequency and severity and is not relieved by rest
and NTG. Requires medical intervention!
8/11/2019 Chronic Heart Diseases
http://slidepdf.com/reader/full/chronic-heart-diseases 21/54
• Treatment seeks to decrease myocardial
oxygen demand and increase oxygen
supply
• Medications
• Oxygen
•
Reduce and control risk factors• Reperfusion therapy may also be
done
8/11/2019 Chronic Heart Diseases
http://slidepdf.com/reader/full/chronic-heart-diseases 22/54
• Nitroglycerin
– Short-term and long-term reduction of myocardial
oxygen consumption through selective vasodilation
• Beta-adrenergic blocking agents – Reduction of myocardial oxygen consumption by
blocking beta-adrenergic stimulation of the heart
•
Calcium channel blocking agents – Negative inotropic effects; indicated in patients not
responsive to beta-blockers; used as primary treatment
for vasospasm
8/11/2019 Chronic Heart Diseases
http://slidepdf.com/reader/full/chronic-heart-diseases 23/54
• Antiplatelet
– Prevention of platelet aggregation
• Anticoagulant medications
– Prevention of thrombus formation
8/11/2019 Chronic Heart Diseases
http://slidepdf.com/reader/full/chronic-heart-diseases 24/54
• Is the following statement True or False?
•
Nitroglycerin tablets should never beremoved and stored in metal or plastic
pillboxes.
8/11/2019 Chronic Heart Diseases
http://slidepdf.com/reader/full/chronic-heart-diseases 25/54
• True
•
Nitroglycerin tablets should never beremoved and stored in metal or plastic
pillboxes.
8/11/2019 Chronic Heart Diseases
http://slidepdf.com/reader/full/chronic-heart-diseases 26/54
• Symptoms and activities, especially those that
precede and precipitate attacks• Risk factors, lifestyle, and health promotion
activities
•Patient and family knowledge
• Adherence to the plan of care
8/11/2019 Chronic Heart Diseases
http://slidepdf.com/reader/full/chronic-heart-diseases 27/54
• Ineffective cardiac tissue perfusion
• Death anxiety• Deficient knowledge
• Noncompliance, ineffective management of
therapeutic regimen
8/11/2019 Chronic Heart Diseases
http://slidepdf.com/reader/full/chronic-heart-diseases 28/54
• Acute pulmonary edema
• Heart failure
•
Cardiogenic shock• Dysrhythmias and cardiac arrest
• Myocardial infarction
8/11/2019 Chronic Heart Diseases
http://slidepdf.com/reader/full/chronic-heart-diseases 29/54
• Goals include the immediate and appropriate
treatment of angina, prevention of angina,reduction of anxiety, awareness of the disease
process, understanding of prescribed care,
adherence to the self-care program, and
absence of complications.
8/11/2019 Chronic Heart Diseases
http://slidepdf.com/reader/full/chronic-heart-diseases 30/54
• Treatment of angina pain is a priority nursingconcern.
• Patient is to stop all activity and sit or rest in bed.
•
Assess the patient while performing othernecessary interventions. Assessment includes VS,and observation for respiratory distress, andassessment of pain. In the hospital setting, theECG is assessed or obtained.
• Administer oxygen.
• Administer medications as ordered or by protocol,usually NTG.
8/11/2019 Chronic Heart Diseases
http://slidepdf.com/reader/full/chronic-heart-diseases 31/54
• Use a calm manner
• Stress-reduction techniques
•
Patient teaching• Addressing patient spiritual needs may
assist in allaying anxieties
•
Address both patient and family needs
ethelRN
8/11/2019 Chronic Heart Diseases
http://slidepdf.com/reader/full/chronic-heart-diseases 32/54
• Lifestyle changes and reduction of risk factors
• Explore, recognize, and adapt behaviors to
avoid to reduce the incidence of episodes of
ischemia
• Teaching regarding disease process
• Medications
• Stress reduction
• When to seek emergency care
8/11/2019 Chronic Heart Diseases
http://slidepdf.com/reader/full/chronic-heart-diseases 33/54
• An area of the myocardium is permanently destroyed.
Usually caused by reduced blood flow in a coronary
artery due to rupture of an atherosclerotic plaque and
subsequent occlusion of the artery by a thrombus.• In unstable angina, the plaque ruptures but the artery is
not completely occluded. Unstable angina and acute
myocardial infarction are considered the same process
but at different point on the continuum.
• The term acute coronary syndrome includes unstable
angina and myocardial infarction.
8/11/2019 Chronic Heart Diseases
http://slidepdf.com/reader/full/chronic-heart-diseases 35/54
• Cardiovascular
• Chest pain or discomfort not relieved by rest or nitroglycerin
palpitations.
• Heart sounds may include S3, S4, and new onset of a murmur.
• Increased jugular venous distention may be seen if the MI has
caused heart failure.
• Blood pressure may be elevated because of sympathetic
stimulation or decreased because of decreased contractility,
impending cardiogenic shock, or medications.
• Irregular pulse may indicate atrial fibrillation.
• In addition to ST-segment and T-wave changes, ECG may
show tachycardia, bradycardia, or other dysrhythmias.
8/11/2019 Chronic Heart Diseases
http://slidepdf.com/reader/full/chronic-heart-diseases 36/54
• Respiratory
• Shortness of breath, dyspnea, tachypnea, andcrackles if MI has caused pulmonary congestion.
• Pulmonary edema may be present.
• Gastrointestinal
• Nausea and vomiting.
• Genitourinary
• Decreased urinary output may indicatecardiogenic shock.
8/11/2019 Chronic Heart Diseases
http://slidepdf.com/reader/full/chronic-heart-diseases 37/54
• Skin• Cool, clammy, diaphoretic, and pale appearance due
to sympathetic stimulation may indicate cardiogenicshock.
•
Neurologic• Anxiety, restlessness, and lightheadedness may
indicate increased sympathetic stimulation or adecrease in contractility and cerebral oxygenation.
• The same symptoms may also herald cardiogenic
shock.• Psychological
• Fear with feeling of impending doom, or denial thatanything is wrong.
8/11/2019 Chronic Heart Diseases
http://slidepdf.com/reader/full/chronic-heart-diseases 38/54
• Laboratory tests—biomarkers
– Creatine Kinase CK-MB
8/11/2019 Chronic Heart Diseases
http://slidepdf.com/reader/full/chronic-heart-diseases 39/54
• Laboratory tests—biomarkers
– Creatine Kinase CK-MB
– Myoglobin
8/11/2019 Chronic Heart Diseases
http://slidepdf.com/reader/full/chronic-heart-diseases 40/54
• Laboratory tests—biomarkers
– Creatine Kinase CK-MB
– Myoglobin – Troponin T or I
8/11/2019 Chronic Heart Diseases
http://slidepdf.com/reader/full/chronic-heart-diseases 41/54
• What is the purpose of an
echocardiogram?
a. Evaluate arterial function of the heart
b. Evaluate ventricular function of the heart
c. Detect hyperkinetic wall motion
d. Identify ischemia changes
8/11/2019 Chronic Heart Diseases
http://slidepdf.com/reader/full/chronic-heart-diseases 42/54
• B
•
The echocardiogram is used to evaluateventricular function. It can detect
hypokinetic and akinetic wall motion and
can determine the ejection fraction.
8/11/2019 Chronic Heart Diseases
http://slidepdf.com/reader/full/chronic-heart-diseases 43/54
• Use rapid transit to the hospital.
• Obtain 12-lead electrocardiogram (ECG) to be read within10 minutes.
• Obtain laboratory blood specimens of cardiac biomarkers,including troponin.
• Obtain other diagnostics to clarify the diagnosis.• Begin routine medical interventions:
– Supplemental oxygen
– Nitroglycerin
–
Morphine – Aspirin 162 to 325 mg
– Beta-blocker
– Angiotensin-converting enzyme inhibitor within 24 hours
– Anticoagulation with heparin and platelet inhibitors
8/11/2019 Chronic Heart Diseases
http://slidepdf.com/reader/full/chronic-heart-diseases 44/54
• Evaluate for indications for reperfusiontherapy:
– Percutaneous coronary intervention
– Thrombolytic therapy• Continue therapy as indicated:
– Intravenous heparin, low-molecular-weightheparin, bivalirudin, or fondaparinux
– Clopidogrel (Plavix)
– Glycoprotein IIb/IIIa inhibitor
• Bed rest for a minimum of 12 to 24 hours
8/11/2019 Chronic Heart Diseases
http://slidepdf.com/reader/full/chronic-heart-diseases 45/54
• A vital component of nursing care!
• Assess all symptoms carefully and compare to
previous and baseline data to detect anychanges or complications.
• Monitor ECG.
8/11/2019 Chronic Heart Diseases
http://slidepdf.com/reader/full/chronic-heart-diseases 46/54
• Ineffective cardiac tissue perfusion
• Risk for fluid imbalance
•Risk for ineffective peripheral tissue perfusion
• Death anxiety
• Deficient knowledge
8/11/2019 Chronic Heart Diseases
http://slidepdf.com/reader/full/chronic-heart-diseases 47/54
• Acute pulmonary edema
• Heart failure
• Cardiogenic shock
• Dysrhythmias and cardiac arrest
• Pericardial effusion and cardiac tamponade
8/11/2019 Chronic Heart Diseases
http://slidepdf.com/reader/full/chronic-heart-diseases 48/54
• Goals include the relief of pain or ischemic
signs and symptoms, prevention of further
myocardial damage, absence of respiratorydysfunction, maintenance of or attainment of
adequate tissues perfusion, reduced anxiety,
adherence to the self-care program, and
absence or early recognition of complications.
8/11/2019 Chronic Heart Diseases
http://slidepdf.com/reader/full/chronic-heart-diseases 49/54
• Percutaneous Transluminal Coronary Angioplasty
• A balloon-tipped catheter is used to open blockedcoronary vessels and resolve ischemia.
•Catheterbased interventions can also be used toopen blocked CABGs.
• The purpose of PTCA is to improve blood flowwithin a coronary artery by compressing and
“cracking” the atheroma.
• The procedure is attempted when theinterventional cardiologist believes that PTCA
can improve blood flow to the myocardium.
8/11/2019 Chronic Heart Diseases
http://slidepdf.com/reader/full/chronic-heart-diseases 50/54
ethelRN
8/11/2019 Chronic Heart Diseases
http://slidepdf.com/reader/full/chronic-heart-diseases 51/54
• The surgeon performs a
median sternotomy and
connects the patient to the
cardiopulmonary bypass (CPB)
machine.
• Next, a blood vessel from
another part of the patient’s body (eg, saphenous vein, left
internal mammary artery) is
grafted distal to the coronary
artery lesion, bypassing theobstruction.
• CPB is then discontinued,
chest tubes and epicardial
pacing wires are placed,and the
incision is closed